Tiotropium Bromide/Olodaterol (Stiolto Respimat): Once-Daily Combination Therapy for the Maintenance of COPD.

Article Details

Citation

Mosley JF 2nd, Smith LL, Dutton BN

Tiotropium Bromide/Olodaterol (Stiolto Respimat): Once-Daily Combination Therapy for the Maintenance of COPD.

P T. 2016 Feb;41(2):97-102.

PubMed ID
26908999 [ View in PubMed
]
Abstract

Tiotropium bromide/olodaterol (Stiolto Respimat): once-daily combination therapy for the maintenance of COPD.

DrugBank Data that Cites this Article

Drug Enzymes
DrugEnzymeKindOrganismPharmacological ActionActions
TiotropiumCytochrome P450 2D6ProteinHumans
No
Substrate
Details